InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Alkermes plc.

ALKS Clue Score59
Ireland Fiscal year ends December CIK 0001520262 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Samuel Joseph Parisi
27 Feb 2024
VP, Finance (Interim PAO)
Sell
2,559
$29.65
$75.87K
Christian Todd Nichols
21 Jun 2022
SVP, Chief Commercial Officer
Sell
7,474
$28.26
$211.20K
Craig C. Hopkinson
23 Feb 2022
EVP R&D, Chief Medical Officer
Sell
11,983
$24.76
$296.65K
Craig C. Hopkinson
18 Feb 2022
EVP R&D, Chief Medical Officer
Sell
2,306
$25.17
$58.04K
Craig C. Hopkinson
9 Jun 2021
EVP R&D, Chief Medical Officer
Sell
882
$24.60
$21.70K
Craig C. Hopkinson
15 Apr 2021
EVP R&D, Chief Medical Officer
Sell
28,920
$19.72
$570.29K
Floyd E Bloom
16 Jul 2018
Director
Sell indirect
20,000
$43.95
$879.02K
James M Frates
12 Jun 2018
SVP, Alks Inc; CFO ALKS
Sell
16,842
$50.00
$842.18K
Iain Michael Brown
29 Dec 2017
SVP Finance & CAO, Alks Inc.
Sell
10,652
$54.81
$583.89K
Robert A Breyer
2 Mar 2017
Director
Sell
4,000
$60.00
$240.00K
Elliot Ehrich
15 Feb 2017
EVP, R&D & CMO, Alkermes, Inc.
Sell
1,000
$58.17
$58.17K
Showing 250 of 294 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 652
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 221
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 9,435,935
Sales filed before the plan box existed 12
History held since 20 Sep 2011